Difference between revisions of "Teaching Points"
Jump to navigation
Jump to search
| Line 1: | Line 1: | ||
* [[DL vs. VL]] | * [[DL vs. VL]] | ||
* [[Methadone]] | * [[Methadone]] | ||
| − | * [[Low vs. High FiO2]] | + | * Extubation strategy [[Low vs. High FiO2]] |
| + | * Esmolol vs Fentanyl induction | ||
| + | * Stanpumpr.io / Posology | ||
| + | * Sustainability priorities (N2O, HVAC, LFA, disposable items) | ||
* pEEG | * pEEG | ||
* Ketorolac 15 vs. 30 | * Ketorolac 15 vs. 30 | ||
Revision as of 22:26, 15 October 2026
- DL vs. VL
- Methadone
- Extubation strategy Low vs. High FiO2
- Esmolol vs Fentanyl induction
- Stanpumpr.io / Posology
- Sustainability priorities (N2O, HVAC, LFA, disposable items)
- pEEG
- Ketorolac 15 vs. 30
- Modified Bier block for propofol infusion pain
- Permissive hypercapnia
- Remimazolam targets: the theoretical initial target concentration of remimazolam may be 0.1 µg/mL for light sedation, 0.2 µg/mL for moderate sedation, and 0.3 µg/mL for deep sedation in elderly patients (70 years), and 1.5 or 2 times those concentrations in middle-aged (45 years) or young adult (20 years) patients. Dose adjust upwards by 10% in females, down by 20% in obesity or ASA III/IV.